The goal of the research is to identify treatments or interventions that can be used on people across age, ethnicity, gender, and lifestyles. If the clinical trial does not represent the population that will ultimately benefit from the study findings, then we won’t have an accurate picture of the efficacy and safety of these treatments in the real world.
However, it is a known issue that many clinical trial populations do not represent the population that will ultimately benefit from the study treatments or interventions.
This course will cover the ethical considerations of diversity and inclusion in clinical trials, identify barriers to diversity in research, share practical examples of what diversity in trials could look like and how to increase diverse participation, as well as how to track the effectiveness of your D&I initiatives.
Attendance at this program has been approved for 0.50 contact hours of research specific continuing education on applications for Maintenance of ACRP’s CCRC®, CCRA®, CPI®, or ACRP-CP® certification designations.
The Society of Clinical Research Associates (SOCRA - www.SOCRA.org) accepts documentation of candidate participation in continuing education programs for recertification if the program is applicable to clinical research regulations, operations or management, or to the candidate’s clinical research therapeutic area. This program offers 0.50 hours of CE credit.
By the end of this course, learners will be able to:
- Articulate the scientific and ethical importance of increasing diversity and inclusion in clinical research.
- Identify why diversity-related goals of sponsors and study sites can differ.
- Recognize the several different barriers to participation for under-represented populations in clinical trials.
By completing/passing this course, you will attain the certificate Advarra Completion Certificate (No Expire)
Your cart is empty